Angiotensin Converting Enzyme Inhibitor
CAS: 35115-60-7
Ref. 3D-FA73196
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
- (S)-1-((S)-1-((2S,3S)-2-((S)-2-((S)-1-((S)-2-((S)-1-((S)-3-(1H-Indol-3-Yl)-2-((S)-5-Oxopyrrolidine-2-Carboxamido)Propanoyl)Pyrrolidine-2-Carboxamido)-5-Guanidinopentanoyl)Pyrrolidine-2-Carboxamido)-5-
Angiotensin Converting Enzyme Inhibitors (ACE) are a class of drugs that inhibit the enzyme angiotensin-converting enzyme, which is responsible for converting angiotensin I to angiotensin II. These drugs are used in the treatment of cardiovascular disorders such as congestive heart failure and hypertension. Angiotensin Converting Enzyme Inhibitors have shown to lower blood pressure and reduce the workload on the heart by reducing blood volume and arterial pressure. Angiotensin Converting Enzyme Inhibitors also decrease the production of angiotensin II, thus decreasing aldosterone release and preventing salt and water retention. ACE inhibitors have been shown to be effective in treating cerebrovascular disease, due to their ability to reduce vascular resistance in the brain.
